em tirzepatide (Zepbound) for weight loss Tirzepatide (Mounjaro) Quiz - rationale:

After working with many people starting semaglutide , a clear pattern emerged: gastrointestinal symptoms tend to happen more during the first weeks and around dose increases

Mounjaro has already gained popularity as an effective drug for diabetes and weight control, while Zepbound, recently approved by the FDA specifically for obesity, is showing great results in people who are looking to lose weight

It helps control glucose levels, reducing spikes after meals

These are pathway-level markers, not response predictions

According to a study in the Journal of Clinical Endocrinology & Metabolism, combining GIP and GLP-1 may lead to more weight loss than using GLP-1 alone